WhatsApp Intervention to Assess the Effect of Messages in Adherence to Antiretrovirals in Young People with HIV in Peru

Universidad Peruana Cayetano Heredia

Status: Active, not recruiting

Conditions: HIV

Treatments: Behavioral: Standardized messages; Behavioral: Self-designed messages

Study type: Interventional

Funder types: Other

Identifiers

NCT06500013

104475

Details and patient eligibility

About

The goal of this clinical trial is to learn which type of messages is more efficacious to improve adherence to medication in young people living with HIV. The main question is aims to answer is:

-Are messages designed by participants (self-designed) more efficacious than messages designed by health providers to improve adherence to antiretroviral treatment (HIV medications)?

Researchers will compare both types of messages to see if one is better than the other in helping participants take their medications.

Participants will:

• Receive either messages designed by themselves or by health providers for 4 months.
• Be able to chat with health providers at any time, with special focus regarding questions about their condition, medications and health services.
• Complete questionnaires via WhatsApp describing how they are taking their medications, and how often they forget to take them.
• Complete questionnaires via WhatsApp describing their opinion about receiving the messages and being able to chat with health providers.

Enrollment: 131 estimated patients

Sex: All

Ages: 18 to 29 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• People living with HIV of age 18-29 at the moment of signing informed consent.
• Being a patient of the study center's Infectious Diseases clinic or National HIV Program, between March 2024 and July 2024.
• Ownership of a mobile phone that supports WhatsApp.

Exclusion criteria

• Being pregnant at the moment of signing informed consent.
• Being illiterate at the moment of signing informed consent.
• Being blind at the moment of signing informed consent

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

131 participants in 2 patient groups

Self-designed messages

Experimental group

Description:

This group of participants will design their own messages, and receive them via mobile messaging up to 3 times a week in the day and time of their choosing, for 16 weeks.

Treatment:

Behavioral: Self-designed messages

Standardized messages

Active Comparator group

Description:

This group of participants will receive messages designed by researchers based on behavioral change theories, up to 3 times a week in the day and time of their choosing, for 16 weeks.

Treatment:

Behavioral: Standardized messages